Biotech in Czechia
The Czech Republic has significant scientific potential,
and biotechnology is one of the most promising fields which
importance will only grow in the future.
companies, research and educational institutions
per year – revenue from product and service sales
foreign direct investments (2003–2025)
employees in life sciences sector
Source: Prague.bio, CzechInvest
What makes the Czech Republic particularly compelling is concentration of:
- high scientific quality per capital
- strong international collaboration
- clinical trial density above regional averages
- and a cost structure that remains competitive within the EU
Strong talent pool
Czech Academy of Sciences and Charles University
are among TOP 100 EU / TOP 350 globally.
Students
Biology
Chemistry
Biochemistry
Czech biotech ecosystem
| Institution | Web | Scope |
|---|
Biotech in the CEE Region
Czechia, Slovakia, Poland, Hungary + Baltics
Human Healthcare Technologies and Services
Growth value-added 2008–2022
GDP
Turnover
R&D Investment
Source: Joint Research Centre, European Comission
Biotech startup environment
Early stage companies
VCs + PE
Source: Joint Research Centre, European Comission
More than half of the Czech Republic’s high-quality
research is conducted with collaborators
from the USA, Germany, and UK alone.
Born in CEE, shaping global medicine
VCs to watch
Curated list of 10 CEE biotech VCs
Startups to watch
Are these the future CEE biotech unicorns? Let’s see!
Czechia Sensible Biotechnologies
Pioneering the design and manufacturing of mRNA therapeutics using living cells.
Czechia Adalid Sciences
Specializes in the development of lipid nanoparticle (LNP) delivery systems for nucleic acid-based therapeutics, such
as mRNA, siRNA, and gene editing tools.
Czechia DIANA Biotechnologies
DIANA stands for DNA linked Inhibitor Antibody Assay – a method that can
precisely detect a variety of diseases.
It targets pathogens and significantly
amplifies the evidence of their presence in biological samples.
Hungary TurbineAI
Virtualizing biological experiments with AI to accelerate drug discovery and
improve clinical translatability. Using its
foundational virtual cell model powered by its lab-in-the-loop, Turbine creates virtual copies of experimental
assays.
Poland iQure Pharma
Clinical-stage biotech company advancing a novel therapeutic approach for CNS disorders by restoring glutamate homeostasis.
Download report in PDF
This report was created by Prague.bio with the support of general partner
IOCB Tech and valuable input from SOTIO Biotech and CzechInvest
